← FDA DRUG APPROVALS

FDA ANDA · ANDA211914

BRINZOLAMIDE

Sponsor: PADAGIS US

APPLICATION
ANDA211914
TYPE
ANDA
ORIGINAL APPROVAL
2023-07-28
LATEST ACTION
2023-07-28
ROUTE
OPHTHALMIC
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
Discontinued

Products

BRINZOLAMIDEDiscontinued
BRINZOLAMIDE 1% · SUSPENSION/DROPS · OPHTHALMIC

Approval history

2023-07-28UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →